No Data
Hainan Development Holdings Nanhai (002163.SZ): The controlling Shareholder and its concerted actors plan to increase Shareholding of 0.1 billion to -0.2 billion yuan in company shares.
On May 8, Gelonghui announced that Hainan Development Holdings Nanhai (002163.SZ) disclosed that its controlling Shareholder, Hainan Provincial Development Holdings Co., Ltd. (referred to as "Hainan Holdings"), and its concerted parties plan to increase their Shareholding in the company within the next six months, through methods allowed by the Shenzhen Stock Exchange trading system (including but not limited to centralized bidding and block trading). The planned amount for the increase is no less than 100 million RMB and no more than 200 million RMB, with the number of shares to be increased not exceeding 2% of the company's total share capital, and the funds will be sourced from the self-raised funds of Hainan Holdings and its concerted parties.
The commitment for tax-exempt Assets injection is about to expire, and Hainan Development Holdings Nanhai, facing tight Cash flow, is turning its focus to e-commerce | Quick Announcement.
① Hainan Development Holdings Nanhai plans to acquire a 51% stake in Wangying Technology for no more than 0.45 billion yuan, stating it will explore a new business model of "taxable + tax-free" integration; ② The valuation given for Wangying Technology in this Trade is approximately 18 times PE, with a net cash flow from operating activities (CFO) of -0.282 billion yuan in the first quarter; ③ The plan for tax-free asset injection frequently faces reversals, and there is less than a week remaining until the expiration date of the asset injection commitment promised by Hainan Development Holdings Nanhai's Shareholder.
Hainan Development: Report for the first quarter of 2025
Hainan Development: Briefing on the main business conditions of the decoration business in the first quarter of 2025
Sanbo Neuroscience (301293.SZ): No plans to develop in Hainan Development Holdings Nanhai at this time.
Gelonghui April 23丨Sanbo Neuroscience (301293.SZ) stated on the interactive platform that the company currently operates 8 Hospitals, located in Peking, Chongqing, Kunming, Fujian, Chengdu, and Zhengzhou and Luoyang in Henan, with two more Hospitals under construction in Xi'an and Hunan; there are currently no plans for Hainan Development Holdings Nanhai.
Hainan Development: 2024 Annual Report
Revenues Not Telling The Story For Hainan Development HoldingsNanhai Co., Ltd. (SZSE:002163)
